Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study.

Reich MM, Horn A, Lange F, Roothans J, Paschen S, Runge J, Wodarg F, Pozzi NG, Witt K, Nickl RC, Soussand L, Ewert S, Maltese V, Wittstock M, Schneider GH, Coenen V, Mahlknecht P, Poewe W, Eisner W, Helmers AK, Matthies C, Sturm V, Isaias IU, Krauss JK, Kühn AA, Deuschl G, Volkmann J.

Brain. 2019 May 1;142(5):1386-1398. doi: 10.1093/brain/awz046.

PMID:
30851091
2.

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.

Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, Sonka K, Jung KY, Kunz D, Dauvilliers Y, Provini F, Lewis SJ, Buskova J, Pavlova M, Heidbreder A, Montplaisir JY, Santamaria J, Barber TR, Stefani A, St Louis EK, Terzaghi M, Janzen A, Leu-Semenescu S, Plazzi G, Nobili F, Sixel-Doering F, Dusek P, Bes F, Cortelli P, Ehgoetz Martens K, Gagnon JF, Gaig C, Zucconi M, Trenkwalder C, Gan-Or Z, Lo C, Rolinski M, Mahlknecht P, Holzknecht E, Boeve AR, Teigen LN, Toscano G, Mayer G, Morbelli S, Dawson B, Pelletier A.

Brain. 2019 Mar 1;142(3):744-759. doi: 10.1093/brain/awz030.

3.

Effect of Low versus High Frequency Subthalamic Deep Brain Stimulation on Speech Intelligibility and Verbal Fluency in Parkinson's Disease: A Double-Blind Study.

Grover T, Georgiev D, Kalliola R, Mahlknecht P, Zacharia A, Candelario J, Hyam J, Zrinzo L, Hariz M, Foltynie T, Limousin P, Jahanshahi M, Tripoliti E.

J Parkinsons Dis. 2019;9(1):141-151. doi: 10.3233/JPD-181368.

PMID:
30594934
4.

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the Movement Disorder Society Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.

5.

Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study.

Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, Stockner H, de Marzi R, Heim B, Djamshidian A, Willeit P, Willeit J, Kiechl S, Valent D, Krismer F, Wenning GK, Nocker M, Mair K, Poewe W, Seppi K.

Gerontology. 2019;65(3):216-228. doi: 10.1159/000492572. Epub 2018 Sep 10.

PMID:
30199864
6.

Parkinsonian signs in patients with cervical dystonia treated with pallidal deep brain stimulation.

Mahlknecht P, Georgiev D, Akram H, Brugger F, Vinke S, Zrinzo L, Hariz M, Bhatia KP, Hariz GM, Willeit P, Rothwell JC, Foltynie T, Limousin P.

Brain. 2018 Oct 1;141(10):3023-3034. doi: 10.1093/brain/awy217.

PMID:
30165511
7.

Reader response: Olfaction and incident Parkinson disease in US white and black older adults.

Mahlknecht P, Kiechl S, Willeit J, Poewe W, Seppi K.

Neurology. 2018 May 15;90(20):940. doi: 10.1212/WNL.0000000000005511. No abstract available.

PMID:
29759998
8.

The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.

Mueller C, Hussl A, Krismer F, Heim B, Mahlknecht P, Nocker M, Scherfler C, Mair K, Esterhammer R, Schocke M, Wenning GK, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2018 Sep;54:90-94. doi: 10.1016/j.parkreldis.2018.04.005. Epub 2018 Apr 3.

9.

Impact of Subthalamic Deep Brain Stimulation Frequency on Upper Limb Motor Function in Parkinson's Disease.

Momin S, Mahlknecht P, Georgiev D, Foltynie T, Zrinzo L, Hariz M, Zacharia A, Limousin P.

J Parkinsons Dis. 2018;8(2):267-271. doi: 10.3233/JPD-171150.

10.

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.

Mahlknecht P, Gasperi A, Djamshidian A, Kiechl S, Stockner H, Willeit P, Willeit J, Rungger G, Poewe W, Seppi K.

Mov Disord. 2018 Mar;33(3):405-413. doi: 10.1002/mds.27281. Epub 2018 Feb 13.

PMID:
29436728
11.

Connectivity derived thalamic segmentation in deep brain stimulation for tremor.

Akram H, Dayal V, Mahlknecht P, Georgiev D, Hyam J, Foltynie T, Limousin P, De Vita E, Jahanshahi M, Ashburner J, Behrens T, Hariz M, Zrinzo L.

Neuroimage Clin. 2018 Jan 28;18:130-142. doi: 10.1016/j.nicl.2018.01.008. eCollection 2018.

12.

MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.

Mangesius S, Hussl A, Krismer F, Mahlknecht P, Reiter E, Tagwercher S, Djamshidian A, Schocke M, Esterhammer R, Wenning G, Müller C, Scherfler C, Gizewski ER, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2018 Jan;46:47-55. doi: 10.1016/j.parkreldis.2017.10.020. Epub 2017 Oct 31.

13.

Caveats of Neurodegenerative Risk Stratification in Idiopathic REM Sleep Behavior Disorder by Use of the MDS Research for Prodromal Parkinson's Disease.

Mahlknecht P, Iranzo A, Stefani A, Serradell M, Santamaria J, Tolosa E, Högl B, Poewe W.

Sleep. 2017 Oct 1;40(10). doi: 10.1093/sleep/zsx131. No abstract available.

PMID:
28958020
14.

Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson's disease.

Akram H, Sotiropoulos SN, Jbabdi S, Georgiev D, Mahlknecht P, Hyam J, Foltynie T, Limousin P, De Vita E, Jahanshahi M, Hariz M, Ashburner J, Behrens T, Zrinzo L.

Neuroimage. 2017 Sep;158:332-345. doi: 10.1016/j.neuroimage.2017.07.012. Epub 2017 Jul 12.

15.

Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia.

Pauls KAM, Krauss JK, Kämpfer CE, Kühn AA, Schrader C, Südmeyer M, Allert N, Benecke R, Blahak C, Boller JK, Fink GR, Fogel W, Liebig T, El Majdoub F, Mahlknecht P, Kessler J, Mueller J, Voges J, Wittstock M, Wolters A, Maarouf M, Moro E, Volkmann J, Bhatia KP, Timmermann L.

Parkinsonism Relat Disord. 2017 Oct;43:38-48. doi: 10.1016/j.parkreldis.2017.06.023. Epub 2017 Jun 28.

16.

Characterization of patients with longstanding idiopathic REM sleep behavior disorder.

Iranzo A, Stefani A, Serradell M, Martí MJ, Lomeña F, Mahlknecht P, Stockner H, Gaig C, Fernández-Arcos A, Poewe W, Tolosa E, Högl B, Santamaria J; SINBAR (Sleep Innsbruck Barcelona) group.

Neurology. 2017 Jul 18;89(3):242-248. doi: 10.1212/WNL.0000000000004121. Epub 2017 Jun 14.

PMID:
28615430
17.

Pyramidal tract activation due to subthalamic deep brain stimulation in Parkinson's disease.

Mahlknecht P, Akram H, Georgiev D, Tripoliti E, Candelario J, Zacharia A, Zrinzo L, Hyam J, Hariz M, Foltynie T, Rothwell JC, Limousin P.

Mov Disord. 2017 Aug;32(8):1174-1182. doi: 10.1002/mds.27042. Epub 2017 Jun 7.

PMID:
28590508
18.

Letter re: Incident parkinsonism in older adults without Parkinson disease.

Mahlknecht P, Kiechl S, Willeit J, Poewe W, Seppi K.

Neurology. 2017 Feb 28;88(9):919. doi: 10.1212/WNL.0000000000003671. No abstract available.

PMID:
28242850
19.

Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.

Mahlknecht P, Krismer F, Poewe W, Seppi K.

Mov Disord. 2017 Apr;32(4):619-623. doi: 10.1002/mds.26932. Epub 2017 Feb 2.

PMID:
28151553
20.

Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.

Krismer F, Pinter B, Mueller C, Mahlknecht P, Nocker M, Reiter E, Djamshidian-Tehrani A, Boesch SM, Wenning GK, Scherfler C, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2017 Feb;35:36-41. doi: 10.1016/j.parkreldis.2016.11.010. Epub 2016 Nov 21.

PMID:
27890451
21.

Consistency of "Probable RBD" Diagnosis with the RBD Screening Questionnaire: A Follow-up Study.

Stefani A, Mahlknecht P, Seppi K, Nocker M, Mair KJ, Hotter A, Stockner H, Willeit J, Kiechl S, Rungger G, Gasperi A, Poewe W, Högl B.

Mov Disord Clin Pract. 2016 Nov 1;4(3):403-405. doi: 10.1002/mdc3.12448. eCollection 2017 May-Jun.

22.

Utility of Nigral Signal Intensity Changes on MR Images to Differentiate Drug-induced Parkinsonism from Parkinson Disease.

De Marzi R, Poewe W, Gizewski ER, Mahlknecht P, Seppi K.

Radiology. 2016 Nov;281(2):651-652. No abstract available.

PMID:
27755935
23.

Ezetimibe-Statin Combination Therapy.

Nußbaumer B, Glechner A, Kaminski-Hartenthaler A, Mahlknecht P, Gartlehner G.

Dtsch Arztebl Int. 2016 Jul 1;113(26):445-53. doi: 10.3238/arztebl.2016.0445.

24.

Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.

Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2016 Oct;31(10):1466-1478. doi: 10.1002/mds.26675. Review.

PMID:
27296904
25.

Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.

Mahlknecht P, Gasperi A, Willeit P, Kiechl S, Stockner H, Willeit J, Rungger G, Sawires M, Nocker M, Rastner V, Mair KJ, Hotter A, Poewe W, Seppi K.

Mov Disord. 2016 Sep;31(9):1405-8. doi: 10.1002/mds.26674. Epub 2016 Jun 6. Review.

PMID:
27273736
26.

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease.

Mahlknecht P, Pechlaner R, Boesveldt S, Volc D, Pinter B, Reiter E, Müller C, Krismer F, Berendse HW, van Hilten JJ, Wuschitz A, Schimetta W, Högl B, Djamshidian A, Nocker M, Göbel G, Gasperi A, Kiechl S, Willeit J, Poewe W, Seppi K.

Mov Disord. 2016 Sep;31(9):1408-13. doi: 10.1002/mds.26637. Epub 2016 May 9. Review.

27.

Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review.

Desai RJ, Thaler KJ, Mahlknecht P, Gartlehner G, McDonagh MS, Mesgarpour B, Mazinanian A, Glechner A, Gopalakrishnan C, Hansen RA.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1078-88. doi: 10.1002/acr.22815. Review.

28.

Plasma fasting cholesterol profiles and age at onset in Parkinson's disease.

Mahlknecht P, Sprenger F, Seppi K, Poewe W.

Mov Disord. 2015 Dec;30(14):1974-5. doi: 10.1002/mds.26452. Epub 2015 Nov 19. No abstract available.

PMID:
26583369
29.

The Concept of Prodromal Parkinson's Disease.

Mahlknecht P, Seppi K, Poewe W.

J Parkinsons Dis. 2015;5(4):681-97. doi: 10.3233/JPD-150685. Review.

30.

Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews.

Sommer I, Griebler U, Mahlknecht P, Thaler K, Bouskill K, Gartlehner G, Mendis S.

BMC Public Health. 2015 Sep 18;15:914. doi: 10.1186/s12889-015-2227-y. Review.

31.

[Guideline development: Going from evidence to recommendations. Challenges and opportunities--a methodologist's view].

Mahlknecht P, Glechner A, Gartlehner G.

Z Evid Fortbild Qual Gesundhwes. 2015;109(4-5):319-29. doi: 10.1016/j.zefq.2015.06.009. Epub 2015 Jul 26. German.

32.

Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.

Poewe W, Mahlknecht P, Krismer F.

Mov Disord. 2015 Sep 15;30(11):1528-38. doi: 10.1002/mds.26334. Epub 2015 Jul 30. Review.

PMID:
26227071
33.

Motoric cognitive risk syndrome: multicenter incidence study.

Mahlknecht P, Kiechl S, Willeit J, Poewe W, Seppi K.

Neurology. 2015 Jul 28;85(4):388-9. doi: 10.1212/01.wnl.0000470376.04336.ea. No abstract available.

PMID:
26215881
34.

Probable RBD and association with neurodegenerative disease markers: A population-based study.

Mahlknecht P, Seppi K, Frauscher B, Kiechl S, Willeit J, Stockner H, Djamshidian A, Nocker M, Rastner V, Defrancesco M, Rungger G, Gasperi A, Poewe W, Högl B.

Mov Disord. 2015 Sep;30(10):1417-21. doi: 10.1002/mds.26350. Epub 2015 Jul 24.

PMID:
26208108
35.

Long-Term Follow-up Investigation of Isolated Rapid Eye Movement Sleep Without Atonia Without Rapid Eye Movement Sleep Behavior Disorder: A Pilot Study.

Stefani A, Gabelia D, Högl B, Mitterling T, Mahlknecht P, Stockner H, Poewe W, Frauscher B.

J Clin Sleep Med. 2015 Nov 15;11(11):1273-9. doi: 10.5664/jcsm.5184.

36.

Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments.

Mahlknecht P, Limousin P, Foltynie T.

J Neurol. 2015 Nov;262(11):2583-95. doi: 10.1007/s00415-015-7790-8. Epub 2015 Jun 3. Review.

PMID:
26037016
37.

Tubular ectasia of the rete testis (TERT). Differential diagnosis of cystic testicular disorders.

Mahlknecht A, Mahlknecht P, Fallaha M, Wieser A.

Arch Ital Urol Androl. 2015 Mar 31;87(1):5-7. doi: 10.4081/aiua.2015.1.5.

38.

Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD.

Mahlknecht P, Iranzo A, Högl B, Frauscher B, Müller C, Santamaría J, Tolosa E, Serradell M, Mitterling T, Gschliesser V, Goebel G, Brugger F, Scherfler C, Poewe W, Seppi K; Sleep Innsbruck Barcelona Group.

Neurology. 2015 Feb 17;84(7):654-8. doi: 10.1212/WNL.0000000000001265. Epub 2015 Jan 21.

PMID:
25609758
39.

Predictors for mild parkinsonian signs: a prospective population-based study.

Mahlknecht P, Kiechl S, Stockner H, Willeit J, Gasperi A, Poewe W, Seppi K.

Parkinsonism Relat Disord. 2015 Mar;21(3):321-4. doi: 10.1016/j.parkreldis.2014.12.021. Epub 2014 Dec 31.

PMID:
25585991
40.

Excitation of rat sympathetic neurons via M1 muscarinic receptors independently of Kv7 channels.

Salzer I, Gafar H, Gindl V, Mahlknecht P, Drobny H, Boehm S.

Pflugers Arch. 2014 Dec;466(12):2289-303. doi: 10.1007/s00424-014-1487-1. Epub 2014 Mar 26.

41.

Movement disorders: new insights into disease mechanisms and treatment.

Poewe W, Mahlknecht P.

Lancet Neurol. 2014 Jan;13(1):9-11. doi: 10.1016/S1474-4422(13)70288-6. Review. No abstract available.

PMID:
24331784
42.

Risk factors and prodromal markers and the development of Parkinson's disease.

Lerche S, Seppi K, Behnke S, Liepelt-Scarfone I, Godau J, Mahlknecht P, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Poewe W, Berg D.

J Neurol. 2014 Jan;261(1):180-7. doi: 10.1007/s00415-013-7171-0. Epub 2013 Nov 5.

PMID:
24190794
43.

Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.

Scherfler C, Esterhammer R, Nocker M, Mahlknecht P, Stockner H, Warwitz B, Spielberger S, Pinter B, Donnemiller E, Decristoforo C, Virgolini I, Schocke M, Poewe W, Seppi K.

Brain. 2013 Oct;136(Pt 10):3028-37. doi: 10.1093/brain/awt234. Epub 2013 Sep 6.

PMID:
24014521
44.

Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study.

Mahlknecht P, Kiechl S, Bloem BR, Willeit J, Scherfler C, Gasperi A, Rungger G, Poewe W, Seppi K.

PLoS One. 2013 Jul 24;8(7):e69627. doi: 10.1371/journal.pone.0069627. Print 2013.

45.

Update on diffusion MRI in Parkinson's disease and atypical parkinsonism.

Meijer FJ, Bloem BR, Mahlknecht P, Seppi K, Goraj B.

J Neurol Sci. 2013 Sep 15;332(1-2):21-9. doi: 10.1016/j.jns.2013.06.032. Epub 2013 Jul 15. Review.

PMID:
23866820
46.

Is there a need to redefine Parkinson's disease?

Mahlknecht P, Poewe W.

J Neural Transm (Vienna). 2013 Sep;120 Suppl 1:S9-17. doi: 10.1007/s00702-013-1038-5. Epub 2013 May 29. Review.

PMID:
23715973
47.

Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.

Mahlknecht P, Seppi K, Stockner H, Nocker M, Scherfler C, Kiechl S, Willeit J, Schmidauer C, Gasperi A, Rungger G, Poewe W.

Neurodegener Dis. 2013;12(4):212-8. doi: 10.1159/000348595. Epub 2013 May 18.

PMID:
23689066
48.

An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes.

Mahlknecht P, Stemberger S, Sprenger F, Rainer J, Hametner E, Kirchmair R, Grabmer C, Scherfler C, Wenning GK, Seppi K, Poewe W, Reindl M.

Proteome Sci. 2012 Nov 23;10(1):71. doi: 10.1186/1477-5956-10-71.

49.

Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.

Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P, Liepelt-Scarfone I, Pausch C, Schneider N, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Gasser T, Poewe W.

Mov Disord. 2013 Feb;28(2):216-9. doi: 10.1002/mds.25192. Epub 2012 Oct 31.

PMID:
23115051
50.

Supplemental Content

Loading ...
Support Center